Cargando…

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th edition

Molecular testing to select the appropriate targeted and standard of care therapies is essential for managing patients with colorectal cancer (CRC). The Japanese Society of Medical Oncology previously published clinical guidelines for molecular testing in CRC. In the third edition published in 2018,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebi, Hiromichi, Bando, Hideaki, Taniguchi, Hiroya, Sunakawa, Yu, Okugawa, Yoshinaga, Hatanaka, Yutaka, Hosoda, Waki, Kumamoto, Kensuke, Nakatani, Kaname, Yamazaki, Kentaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540970/ https://www.ncbi.nlm.nih.gov/pubmed/32667108 http://dx.doi.org/10.1111/cas.14567

Ejemplares similares

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition
por: Yamazaki, Kentaro, et al.
Publicado: (2018)

Precision Oncology and the Universal Health Coverage System in Japan
por: Ebi, Hiromichi, et al.
Publicado: (2019)

Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11
por: Taniguchi, Hiroya, et al.
Publicado: (2015)

REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer
por: Nakajima, Hiromichi, et al.
Publicado: (2021)

Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition
por: Mishima, Saori, et al.
Publicado: (2019)

SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors
por: Nakamura, Yoshiaki, et al.
Publicado: (2021)

Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report
por: Onishi, Sachiyo, et al.
Publicado: (2020)

Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer
por: Taniguchi, Hiroya, et al.
Publicado: (2021)

A Cross-Sectional Study on the Relationship between Oral Function and Sarcopenia in Japanese Patients with Regular Dental Maintenance
por: Shirahase, Ryuichi, et al.
Publicado: (2022)

Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
por: Naito, Yoichi, et al.
Publicado: (2020)

Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors
por: Akagi, Kiwamu, et al.
Publicado: (2021)

Cancer-associated gene analysis of cervical cytology samples and liquid-based cytology significantly improve endometrial cancer diagnosis sensitivity
por: Nimura, Ryo, et al.
Publicado: (2022)

Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study
por: Yuki, Satoshi, et al.
Publicado: (2023)

Polymorphisms in CPT1B and CPT2 have no significant effect on plasma carnitine levels in Japanese cancer patients
por: Hishida, Asahi, et al.
Publicado: (2019)

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
por: Honda, Kazunori, et al.
Publicado: (2019)

Deletion of Dinucleotide Repeat (Δ14 Allele) in the Methylthioadenosine Phosphorylase (MTAP) Promoter and the Allelotype of MTAP Promoter in the Japanese Population
por: Kadariya, Yuwaraj, et al.
Publicado: (2002)

Successful IMRT and concurrent chemotherapy for a patient with intrathoracic extensive‐stage small cell lung cancer
por: Horio, Yoshitsugu, et al.
Publicado: (2022)

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study
por: Kotani, Daisuke, et al.
Publicado: (2021)

Fundamentals of Oncology. Second Edition
por: Bondy, Philip K.
Publicado: (1981)

Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
por: Adachi, Yuta, et al.
Publicado: (2021)

BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2020)

Japanese structure survey of radiation oncology in 2012
por: Numasaki, Hodaka, et al.
Publicado: (2019)

Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer
por: Miyo, Masaaki, et al.
Publicado: (2020)

CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
por: Taniguchi, Hiroya, et al.
Publicado: (2021)

Editing DNA Methylation in Mammalian Embryos
por: Yamazaki, Taiga, et al.
Publicado: (2020)

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
por: Mishima, Saori, et al.
Publicado: (2023)

Japanese structure survey of radiation oncology in 2010
por: Numasaki, Hodaka, et al.
Publicado: (2019)

Japanese Structure Survey of Radiation Oncology in 2011
por: Numasaki, Hodaka, et al.
Publicado: (2019)

Oxford Textbook of Oncology, Second Edition
por: Armitage, J O
Publicado: (2002)

Principles of Molecular Oncology: Second Edition
por: Laman, H
Publicado: (2004)

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2023)

Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children
por: Sunakawa, Keisuke, et al.
Publicado: (2007)

Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report
por: Tanimoto, Azusa, et al.
Publicado: (2018)

Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center
por: Ando, Masashi, et al.
Publicado: (2023)

Evidence-Based Paediatric Oncology: Second Edition
por: Anderson, J
Publicado: (2008)

Clinical Gynecologic Oncology. 3rd Edition
por: Rosenthal, Seth A.
Publicado: (1989)

The Basic Science of Oncology. 2nd Edition
por: Twentyman, P.R.
Publicado: (1993)

Introduction to the special edition on immunotherapy and radiation oncology
por: Bornstein, Sophia, et al.
Publicado: (2018)

Polymorphism in the KCNA3 Gene Is Associated with Susceptibility to Autoimmune Pancreatitis in the Japanese Population
por: Ota, Masao, et al.
Publicado: (2011)

An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis
por: Okugawa, Kaoru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5f708vjo78mhnsab4r34qgac8s